[{"Assets_0_FY_USD":1320700000.0,"CIK":"899923","CommonStockSharesConverted_0_FY_shares":80000000.0,"CommonStockSharesOutstanding_0_FY_shares":80000000.0,"Country":"United States","EarningsPerShareBasic_4_FY_USD":-0.35,"EarningsPerShareDiluted_4_FY_USD":-0.35,"Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"1850258412.0","NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":18200000.0,"NetIncomeLossConverted_4_FY_USD":-27200000.0,"OfficialName":"Myriad Genetics Inc. Common Stock","RevenuesConverted_4_FY_USD":690600000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquityConverted_0_FY_USD":967800000.0,"StockholdersEquity_0_FY_USD":967800000.0,"Ticker":"MYGN","WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":78000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":78000000.0,"filed":"20220225","footnote":"nan","form":"10-K","fp":"FY","fy":"2021.0","name":"MYRIAD GENETICS INC","period":"20211231","qtrs":"0","uom":"USD"}]